Schizophrenia

Peter F Buckley, Adriana Elena Foster

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Schizophrenia is the most serious and disabling of all mental disorders, affecting just under 1 % of the population. While its etiological bases remain obscure and consequently its nosological boundaries are uncertain, the condition classically has its onset in childhood or early adolescence [1]. It is characterized by (1) “positive” psychotic symptoms like delusions (fi xed false ideas that are held with unshakable conviction), hallucinations (perceptions without a stimulus), and thought disorder (diffi culty in assembling a coherent stream of speech); (2) socalled negative symptoms like lack of motivation and pleasure, inability of expressing the full range of emotions, neglect of personal appearance, and disinterest in life events; and (3) cognitive impairment (memory and attention diffi culties) [2]. All of these attributes, persistent over time, culminate in a decline in social and occupational performance. These features–coupled with the consequences of sustained impairment–result in comorbid depression (see chapter “Major depressive disorder”) among people with schizophrenia. Approximately 50 % of patients attempt and about 4 % of patients commit suicide. Schizophrenia is poorly understood by the public, and it is often highly stigmatizing [3].

Original languageEnglish (US)
Title of host publicationMetabolism of Human Diseases
Subtitle of host publicationOrgan Physiology and Pathophysiology
PublisherSpringer-Verlag Wien
Pages17-22
Number of pages6
ISBN (Electronic)9783709107157
ISBN (Print)9783709107140
DOIs
StatePublished - Jan 1 2014

Fingerprint

Schizophrenia
Pleasure
Delusions
Hallucinations
Major Depressive Disorder
Mental Disorders
Suicide
Motivation
Emotions
Depression
Population
Cognitive Dysfunction

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Buckley, P. F., & Foster, A. E. (2014). Schizophrenia. In Metabolism of Human Diseases: Organ Physiology and Pathophysiology (pp. 17-22). Springer-Verlag Wien. https://doi.org/10.1007/978-3-7091-0715-7_4

Schizophrenia. / Buckley, Peter F; Foster, Adriana Elena.

Metabolism of Human Diseases: Organ Physiology and Pathophysiology. Springer-Verlag Wien, 2014. p. 17-22.

Research output: Chapter in Book/Report/Conference proceedingChapter

Buckley, PF & Foster, AE 2014, Schizophrenia. in Metabolism of Human Diseases: Organ Physiology and Pathophysiology. Springer-Verlag Wien, pp. 17-22. https://doi.org/10.1007/978-3-7091-0715-7_4
Buckley PF, Foster AE. Schizophrenia. In Metabolism of Human Diseases: Organ Physiology and Pathophysiology. Springer-Verlag Wien. 2014. p. 17-22 https://doi.org/10.1007/978-3-7091-0715-7_4
Buckley, Peter F ; Foster, Adriana Elena. / Schizophrenia. Metabolism of Human Diseases: Organ Physiology and Pathophysiology. Springer-Verlag Wien, 2014. pp. 17-22
@inbook{5b32850c6bdc4c8997f492292dc0a3b1,
title = "Schizophrenia",
abstract = "Schizophrenia is the most serious and disabling of all mental disorders, affecting just under 1 {\%} of the population. While its etiological bases remain obscure and consequently its nosological boundaries are uncertain, the condition classically has its onset in childhood or early adolescence [1]. It is characterized by (1) “positive” psychotic symptoms like delusions (fi xed false ideas that are held with unshakable conviction), hallucinations (perceptions without a stimulus), and thought disorder (diffi culty in assembling a coherent stream of speech); (2) socalled negative symptoms like lack of motivation and pleasure, inability of expressing the full range of emotions, neglect of personal appearance, and disinterest in life events; and (3) cognitive impairment (memory and attention diffi culties) [2]. All of these attributes, persistent over time, culminate in a decline in social and occupational performance. These features–coupled with the consequences of sustained impairment–result in comorbid depression (see chapter “Major depressive disorder”) among people with schizophrenia. Approximately 50 {\%} of patients attempt and about 4 {\%} of patients commit suicide. Schizophrenia is poorly understood by the public, and it is often highly stigmatizing [3].",
author = "Buckley, {Peter F} and Foster, {Adriana Elena}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-3-7091-0715-7_4",
language = "English (US)",
isbn = "9783709107140",
pages = "17--22",
booktitle = "Metabolism of Human Diseases",
publisher = "Springer-Verlag Wien",

}

TY - CHAP

T1 - Schizophrenia

AU - Buckley, Peter F

AU - Foster, Adriana Elena

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Schizophrenia is the most serious and disabling of all mental disorders, affecting just under 1 % of the population. While its etiological bases remain obscure and consequently its nosological boundaries are uncertain, the condition classically has its onset in childhood or early adolescence [1]. It is characterized by (1) “positive” psychotic symptoms like delusions (fi xed false ideas that are held with unshakable conviction), hallucinations (perceptions without a stimulus), and thought disorder (diffi culty in assembling a coherent stream of speech); (2) socalled negative symptoms like lack of motivation and pleasure, inability of expressing the full range of emotions, neglect of personal appearance, and disinterest in life events; and (3) cognitive impairment (memory and attention diffi culties) [2]. All of these attributes, persistent over time, culminate in a decline in social and occupational performance. These features–coupled with the consequences of sustained impairment–result in comorbid depression (see chapter “Major depressive disorder”) among people with schizophrenia. Approximately 50 % of patients attempt and about 4 % of patients commit suicide. Schizophrenia is poorly understood by the public, and it is often highly stigmatizing [3].

AB - Schizophrenia is the most serious and disabling of all mental disorders, affecting just under 1 % of the population. While its etiological bases remain obscure and consequently its nosological boundaries are uncertain, the condition classically has its onset in childhood or early adolescence [1]. It is characterized by (1) “positive” psychotic symptoms like delusions (fi xed false ideas that are held with unshakable conviction), hallucinations (perceptions without a stimulus), and thought disorder (diffi culty in assembling a coherent stream of speech); (2) socalled negative symptoms like lack of motivation and pleasure, inability of expressing the full range of emotions, neglect of personal appearance, and disinterest in life events; and (3) cognitive impairment (memory and attention diffi culties) [2]. All of these attributes, persistent over time, culminate in a decline in social and occupational performance. These features–coupled with the consequences of sustained impairment–result in comorbid depression (see chapter “Major depressive disorder”) among people with schizophrenia. Approximately 50 % of patients attempt and about 4 % of patients commit suicide. Schizophrenia is poorly understood by the public, and it is often highly stigmatizing [3].

UR - http://www.scopus.com/inward/record.url?scp=84956749425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956749425&partnerID=8YFLogxK

U2 - 10.1007/978-3-7091-0715-7_4

DO - 10.1007/978-3-7091-0715-7_4

M3 - Chapter

AN - SCOPUS:84956749425

SN - 9783709107140

SP - 17

EP - 22

BT - Metabolism of Human Diseases

PB - Springer-Verlag Wien

ER -